Biotech by one-year price change
How far the share price has moved over the last 52 weeks.
CRISPR Therapeutics has the lowest figure of the 24 biotech ranked by one-year price change, at -20.9%, followed by BioNTech (-16.3%) and argenx (+3.60%). Figures as of 18 Nov 2026, 16:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- CRISPR Therapeutics-20.9%
- Median
- +40.0%
- Combined market value
- ZAR 14.5T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | 1 year ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | CRISPR TherapeuticsCRSP · Health Care | -20.9% | ZAR 69.7B | ZAR 718.30 | 3.61% up | 21% down | ||
| 2 | BioNTechBNTX · Health Care | -16.3% | ZAR 359.6B | ZAR 1,450.58 | 1.00% down | 16% down | ||
| 3 | argenxARGX · Health Care | +3.60% | ZAR 1.02T | ZAR 16,234.07 | 0.77% down | 4% up | ||
| 4 | RepligenRGEN · Health Care | +4.58% | ZAR 188.4B | ZAR 2,947.79 | 5.27% up | 5% up | ||
| 5 | QiagenQGEN · Health Care | +12.0% | ZAR 176.6B | ZAR 855.40 | 0.42% down | 12% up | ||
| 6 | Scholar Rock HoldingSRRK · Health Care | +13.6% | ZAR 98.8B | ZAR 809.64 | 4.02% up | 14% up | ||
| 7 | Neurocrine BiosciencesNBIX · Health Care | +20.2% | ZAR 284B | ZAR 2,805.68 | 2.07% down | 20% up | ||
| 8 | VaxcytePCVX · Health Care | +22.2% | ZAR 160.7B | ZAR 1,015.29 | 1.01% down | 22% up | ||
| 9 | Bio-TechneTECH · Health Care | +25.6% | ZAR 197.3B | ZAR 1,255.73 | 0.13% up | 26% up | ||
| 10 | Gilead SciencesGILD · Health Care | +32.9% | ZAR 3.62T | ZAR 2,920.42 | 0.66% down | 33% up | ||
| 11 | AmgenAMGN · Health Care | +33.7% | ZAR 4.17T | ZAR 7,712.56 | 2.46% down | 34% up | ||
| 12 | Halozyme TherapeuticsHALO · Health Care | +36.6% | ZAR 190.9B | ZAR 1,674.79 | 1.07% up | 37% up | ||
| 13 | ImmunovantIMVT · Health Care | +43.4% | ZAR 119.7B | ZAR 578.52 | 0.89% up | 43% up | ||
| 14 | Krystal BiotechKRYS · Health Care | +46.3% | ZAR 159B | ZAR 5,366.87 | 4.11% up | 46% up | ||
| 15 | BiogenBIIB · Health Care | +49.3% | ZAR 638.5B | ZAR 4,319.20 | 0.26% down | 49% up | ||
| 16 | ExelixisEXEL · Health Care | +62.6% | ZAR 291.2B | ZAR 1,193.31 | 0.89% up | 63% up | ||
| 17 | CG OncologyCGON · Health Care | +85.3% | ZAR 123.8B | ZAR 1,385.66 | 1.66% up | 85% up | ||
| 18 | Kymera TherapeuticsKYMR · Health Care | +87.5% | ZAR 177.5B | ZAR 2,079.61 | 0.89% down | 87% up | ||
| 19 | Adaptive BiotechnologiesADPT · Health Care | +88.1% | ZAR 78.5B | ZAR 485.20 | 1.37% down | 88% up | ||
| 20 | Revolution MedicinesRVMD · Health Care | +131% | ZAR 596.7B | ZAR 2,758.54 | 1.80% down | 131% up | ||
| 21 | ImmunityBioIBRX · Health Care | +193% | ZAR 121.2B | ZAR 113.96 | 5.43% up | 193% up | ||
| 22 | Twist BioscienceTWST · Health Care | +340% | ZAR 135B | ZAR 1,979.81 | 2.37% up | 340% up | ||
| 23 | Kodiak SciencesKOD · Health Care | +396% | ZAR 108.4B | ZAR 1,657.96 | 0.81% down | 396% up | ||
| 24 | ModernaMRNA · Health Care | +755% | ZAR 1.41T | ZAR 3,485.30 | 2.39% down | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2668 ZAR).
Questions and answers
Which biotech have the lowest one-year price change?
CRISPR Therapeutics (-20.9%), BioNTech (-16.3%) and argenx (+3.60%) have the lowest one-year price change of the 24 biotech ranked here as of 18 Nov 2026, 16:40 UTC.
How many biotech are in this ranking?
24 are ranked by one-year price change.
What are these biotech worth together?
The 24 biotech ranked by one-year price change have a combined market value of ZAR 14.5T as of 18 Nov 2026, 16:40 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.